English
Ortin Global Q4 Results
- BSE: 539287
- NSE: ORTINGLOBE
- ISIN: INE749B01020
- Sector: Biotechnology & Drugs
BSE
13.01
0.00 (0.00%)
0.00 (0.00%)Volume0.00
Updated: Thu 22 Jan, 2026 | 16:00:03
NSE
12.58
0.46 (3.80%)
0.46 (3.80%)Volume366.00
Updated: Fri 23 Jan, 2026 | 15:29:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Ortin Global Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 0.25 | 0.15 | 65.42% | 3.41 | -92.75% |
| Depreciation/ Amortization | 0.00 | 0.00 | 0.00% | 0.05 | 0.00% |
| Operating Income | -0.20 | -0.12 | 74.14% | -3.27 | -93.82% |
| Net Income | -0.16 | -0.11 | 53.51% | -4.14 | -96.04% |
| Other Operating Expenses Total | 0.20 | 0.09 | 121.44% | 3.11 | -93.47% |
| Net Income Before Taxes | -0.16 | -0.10 | 58.97% | -3.18 | -94.93% |
| Total Revenue | 0.05 | 0.03 | 35.22% | 0.14 | -68.72% |
| Selling/ General/ Admin Expenses Total | 0.03 | 0.04 | -18.65% | 0.09 | -60.07% |
| Diluted Normalized EPS | -0.20 | -0.15 | 38.56% | -5.10 | -96.06% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.